GE HEALTHCARE TECHNOLOGIES INC.

NASDAQ: GEHC (GE HealthCare Technologies Inc.)

最近更新时间: 10小时之前

79.80

0.23 (0.29%)

前收盘价格 79.57
收盘价格 78.94
成交量 742,079
平均成交量 (3个月) 3,135,653
市值 36,492,382,208
市盈率 (P/E TTM) 18.39
预期市盈率 (P/E Forward) 17.15
价格/销量 (P/S) 1.88
股市价格/股市净资产 (P/B) 4.37
52周波幅
74.51 (-6%) — 94.80 (18%)
利润日期 30 Apr 2025 - 14 May 2025
股息率 (DY TTM) 0.16%
营业毛利率 10.13%
营业利益率 (TTM) 16.66%
稀释每股收益 (EPS TTM) 4.34
季度收入增长率 (YOY) 2.20%
季度盈利增长率 (YOY) 78.90%
总债务/股东权益 (D/E MRQ) 108.37%
流动比率 (MRQ) 1.04
营业现金流 (OCF TTM) 1.95 B
杠杆自由现金流 (LFCF TTM) 1.86 B
资产报酬率 (ROA TTM) 5.77%
股东权益报酬率 (ROE TTM) 25.69%

市场趋势

短期 中期
行业 Health Information Services (US) 混合的 混合的
Health Information Services (全球的) 混合的 混合的
股票 GE HealthCare Technologies Inc. 看涨 看涨

AIStockmoo 评分

0.4
分析师共识 5.0
内部交易活动 NA
价格波动 2.0
技术平均移动指标 -5.0
技术振荡指标 -0.5
平均 0.38

相关股票

股票 市值 DY P/E(TTM) P/B
GEHC 36 B 0.16% 18.39 4.37
TEM 8 B - - 180.35
HQY 8 B - 81.07 3.69
WAY 7 B - - 2.35
RCM 6 B - - 2.14
PRVA 3 B - 215.18 4.35

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).

部门 Healthcare
行业 Health Information Services
投资方式 Mid Core
内部持股比例 0.20%
机构持股比例 88.35%
52周波幅
74.51 (-6%) — 94.80 (18%)
目标价格波幅
100.00 (25%) — 110.00 (37%)
110.00 (Citigroup, 37.85%) 购买
103.00 (29.07%)
100.00 (Goldman Sachs, 25.31%) 购买
平均值 104.00 (30.33%)
总计 4 购买
平均价格@调整类型 89.39
公司 日期 目标价格 调整类型 价格@调整类型
Goldman Sachs 11 Mar 2025 100.00 (25.31%) 购买 85.59
Wells Fargo 14 Feb 2025 103.00 (29.07%) 购买 92.21
Citigroup 13 Feb 2025 110.00 (37.84%) 购买 93.48
Jefferies 08 Jan 2025 103.00 (29.07%) 购买 86.26

该时间范围内无数据。

日期 类型 细节
02 Apr 2025 公告 FDA Watch: The Quiet Gold Rush in AI-Powered Medical Devices
31 Mar 2025 公告 GE HealthCare Completes Acquisition of Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan
28 Mar 2025 公告 GE HealthCare unveils Revolution™ Vibe CT system with Unlimited One-Beat Cardiac imaging and AI Solutions
27 Mar 2025 公告 ACC 2025: GE HealthCare announces the U.S. launch of pivotal innovations that will help transform the cardiology care pathway
27 Mar 2025 公告 GE HealthCare announces cash dividend for first quarter of 2025
20 Mar 2025 公告 GE HealthCare launches AI-driven, patient-friendly Invenia ABUS Premium to accelerate scanning and drive early cancer detection in dense breasts
18 Mar 2025 公告 GE HealthCare and NVIDIA reimagine diagnostic imaging with autonomous X-ray and ultrasound solutions
17 Mar 2025 公告 GE HealthCare expands invasive cardiology solutions portfolio with AltiX AI.i for elevated experience in catheterization lab and electrophysiology procedures
04 Mar 2025 公告 GE HealthCare Advances Its Cloud Strategy by Unveiling the Genesis Portfolio to Improve Speed of Digital Innovation Adoption
27 Feb 2025 公告 GE HealthCare names new president and CEO, China
26 Feb 2025 公告 GE HealthCare unveils Freelium, a next-generation sealed magnet platform at ECR 2025 to support equitable and sustainable access to MR
25 Feb 2025 公告 Patients in the US undergo first doses of GE HealthCare’s new PET radiotracer, Flyrcado (flurpiridaz F 18) injection
13 Feb 2025 公告 GE HealthCare reports fourth quarter and full year 2024 financial results
10 Feb 2025 公告 GE HealthCare management to present at upcoming investor conference
31 Jan 2025 公告 GE HealthCare Invests $138 Million in Cork, Ireland Manufacturing Facility to Address Increasing Contrast Media Demand
29 Jan 2025 公告 GE HealthCare named to 2025 Fortune World’s Most Admired Companies™ list
28 Jan 2025 公告 GE HealthCare unveils enhanced Voluson Expert Series women’s health ultrasound systems with focus on early detection and exam efficiency
15 Jan 2025 公告 University of California San Francisco and GE HealthCare Launch a Joint Research Program to Drive Innovations in Imaging, Brain Health and Precision Oncology
14 Jan 2025 公告 Sutter Health and GE HealthCare enter strategic partnership to benefit patients, physicians and clinicians with advanced, AI-powered imaging
显示更多
股息率 (DY TTM) 0.16%
2年平均股息收益率 0.13%
股息支付比率 2.76%
预计下次股息支付 Aug 2025
除息日 公告日期 支付日期 详情
25 Apr 2025 27 Mar 2025 15 May 2025 0.035 现金
14 Jan 2025 21 Nov 2024 14 Feb 2025 0.035 现金
18 Oct 2024 18 Sep 2024 15 Nov 2024 0.03 现金
19 Jul 2024 26 Jun 2024 15 Aug 2024 0.03 现金
18 Apr 2024 22 Mar 2024 15 May 2024 0.03 现金
12 Jan 2024 08 Dec 2023 15 Feb 2024 0.03 现金
19 Oct 2023 22 Sep 2023 15 Nov 2023 0.03 现金
20 Jul 2023 23 Jun 2023 15 Aug 2023 0.03 现金
22 May 2023 25 Apr 2023 15 Jun 2023 0.03 现金

每年股息收益率

年份 每年总股息 ($) 频率/年份 收益率 %
2025 0.070 2 0.09
2024 0.120 4 0.15
2023 0.090 3 0.12

支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2025 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票